 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 539 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Saido T. on PAPER: Lesné SE. et al., 2013, The group led by Karen Ashe presents an important finding that Aβ*56, not dimers or trimers,... 26 Apr 2013.
|
|
|
 |
|
|
Saido T. on PAPER: Zeng F. et al., 2013, This is a nice update of [18F]-labeled PET ligands for amyloid imaging. 26 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Cohen RM. et al., 2013, This work deserves a lot of attention. One thing that is unclear is the definition of tauopathy. 26 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Tomita T. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Hilpert H. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Rowe CC. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Chouliaras L. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Sharoyan S. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Duboff B. et al., 2013, Recommendation Only. 24 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Landau SM. et al., 2013, This is an important paper which describes the temporal relationship between changes in CSF Aβ42... 9 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Wirth M. et al., 2013, This work strongly suggests that the molecular mechanism(s) downstream of Aβ deposition need to... 9 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Suberbielle E. et al., 2013, A unique viewpoint! 1 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Nyström S. et al., 2013, Recommendation Only. 1 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Head E. et al., 2013, Recommendation Only. 1 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Araki W. et al., 2013, Recommendation Only. 1 Apr 2013.
|
|
|
|
|
|
Saido T. on PAPER: Watt AD. et al., 2013, Important to note. 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Small GW. et al., 2013, Interesting! 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Vestergaard MC. et al., 2013, Solid work. This may lead to elucidation of mechanism(s) for tauopathy. 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Lehmann M. et al., 2013, This work is consistent with the observation that amyloid deposition starts about 25 years... 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Kimura T. et al., 2013, This is a very important work demonstrating the potential relationship between Pin1 and tauopathy. 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Chen RH. et al., 2013, Interesting! 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Gao L. et al., 2013, What happens to calpastatin, calpain-specific inhibitor protein? 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Gold A. et al., 2013, This is an interesting paper that implies that synucleinopathy in CNS may be transmitted to... 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Johnson KA. et al., 2013, Good to know. 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Sohma Y. et al., 2013, Recommendation Only. 6 Feb 2013.
|
|
|
|
|
|
Saido T. on PAPER: Burke KA. et al., 2013, Recommendation Only. 28 Jan 2013.
|
|
|
|
|
|
Saido T. on PAPER: Manzine PR. et al., 2013, Recommendation Only. 21 Jan 2013.
|
|
|
|
|
|
Saido T. on PAPER: Jinwal UK. et al., 2012, Recommendation Only. 7 Jan 2013.
|
|
|
|
|
|
Saido T. on PAPER: Berchtold NC. et al., 2013, Recommendation Only. 7 Jan 2013.
|
|
|
|
|
|
Saido T. on PAPER: Landau SM. et al., 2012, We need a selective PET ligand for tauopathy. 9 Nov 2012.
|
|
|
|
|
|
|
1 to 30 of 539 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
